Nephroureterectomy (also termed radical nephroureterectomy [RNU] or ureteronephrectomy) is the en bloc surgical removal of the entire kidney, the full length of the ipsilateral ureter, and a circumferential cuff of bladder wall surrounding the ureteral orifice — the oncologic gold-standard operation for upper tract urothelial carcinoma (UTUC) arising in the renal pelvis (coded C65.1/C65.2) or ureter (coded C66.1/C66.2). The rationale for removing the entire urothelial lining from renal pelvis to bladder orifice is field cancerization — urothelial carcinoma is a multifocal disease capable of seeding anywhere along the urothelial mucosa, making incomplete ureterectomy a significant risk factor for ureteral stump recurrence. The bladder cuff excision is a non-negotiable component of oncologically sound nephroureterectomy: leaving even a small intramural ureteral segment behind is associated with a 30-75% ureteral stump recurrence rate. The procedure is performed via: open approach (two incisions or single extended flank incision — CPT 50234/50236); laparoscopic or robotic-assisted approach (CPT 50548) with open or endoscopic bladder cuff management; or hand-assisted laparoscopic technique. For AAPC-certified inpatient profee coders, the single most critical coding distinction in nephroureterectomy is whether total ureterectomy with bladder cuff (CPT 50234, 50236, 50548) or only partial ureterectomy (CPT 50220, 50546) was performed — these are fundamentally different CPT codes with significantly different RVUs and global periods. The operative report must state complete ureter removed AND bladder cuff excised to support the total ureterectomy codes.
The dominant combining form for all renal anatomy and pathology; cognate with Latin nefrones, Old Norse nyra, German Niere; applied to the kidney since Hippocratic medical texts of the 5th century BCE
Greek οὐρητήρ (ourētḗr) — “the channel that carries urine”; from ourein — “to urinate”; from ouron — “urine”
Distinguished from urethra (the terminal discharge channel) by Galen in the 2nd century CE; the two terms were confused in early anatomy — the definitive distinction was formalized by Vesalius in 1543
Greek ἐκτομή (ektomḗ) — “a cutting out”; from ek- (out) + temnein (to cut); PIE root *tem- — “to cut”
The standard surgical suffix meaning complete excision/removal; distinguished from -tomy (incision) and -stomy (creation of opening)
The compound nephroureterectomy was constructed from three established Greek-derived surgical roots as the procedure itself was developed in the late 19th and early 20th century. The first documented nephrectomy was performed by German surgeon Gustav Simon in 1869, though the concept of removing the complete ureter with the kidney followed as surgeons recognized the risk of ureteral stump carcinoma. The term ureteronephrectomy (Greek root order reversed) is used synonymously in British and European urology literature, while nephroureterectomy is the dominant American clinical term. The synonym radical nephroureterectomy (RNU) was codified in 1952 by McDonald, Priestley, and Heintzelmann, who established the oncologic rationale for including the bladder cuff. The abbreviation RNU entered common usage in urology literature by the 1990s with the expansion of laparoscopic approaches, which transformed a historically morbid two-incision open procedure into a significantly less invasive operation while maintaining oncologic equivalency.
🔀 ALIASES / ALTERNATE TERMS
Term
Relationship
RNU
Standard abbreviation in urology and oncology; acceptable in documentation; recognized in coding context
Radical nephroureterectomy
Emphasizes oncologic intent — en bloc removal including bladder cuff; same CPT as total nephroureterectomy
Ureteronephrectomy
Synonym — Greek root order reversed; standard British/European term; no separate CPT
⚠️ NOT nephroureterectomy — nephrectomy alone does NOT include total ureterectomy; CPT 50220 (open partial ureterectomy) or 50240 (radical nephrectomy) — ureter removal extent must be confirmed from operative report
Simple nephrectomy
⚠️ Completely distinct — removal of a non-oncologic kidney (e.g., end-stage renal disease, renovascular hypertension) without ureterectomy; CPT 50230 (open); do NOT use for UTUC
🔗 RELATED TERMS
Upper tract urothelial carcinoma (UTUC) — malignancy of the urothelial lining of the renal pelvis and/or ureter; the primary indication for nephroureterectomy; renal pelvis = C65.1/C65.2; ureter = C66.1/C66.2; accounts for ~5-10% of all urothelial cancers
Urothelial carcinoma — also called transitional cell carcinoma (TCC); the predominant cell type in UTUC (~90% of cases); arises from the transitional epithelium lining the entire urinary collecting system from renal calyx to proximal urethra
Field cancerization — the urothelial-wide susceptibility to multifocal carcinoma; the oncologic rationale for complete ureterectomy with bladder cuff; explains why leaving ureteral stump causes high local recurrence
Bladder cuff excision — circumferential removal of bladder wall segment surrounding the intramural ureter; mandatory component of oncologically complete nephroureterectomy; primary determinant of whether CPT 50234/50236/50548 vs. 50220/50546 is correct
Ureteral stump — remaining intramural ureter if bladder cuff not excised; site of 30-75% recurrence if left in situ; documented indication for completion ureterectomy (CPT 50650) if found on surveillance
Intravesical chemotherapy — single post-operative instillation of mitomycin C into the bladder immediately after RNU; reduces bladder recurrence from 35% to ~22%; standard of care; not separately CPT-billed as part of the surgical encounter
Lynch syndrome — hereditary mismatch repair deficiency; significantly elevated UTUC risk; germline testing supported by ICD-10-CM Z15.09 (susceptibility to other malignant neoplasm); IHC or MSI testing of tumor specimen = CPT 88341/88342
Radical nephrectomy — removes kidney + Gerota’s fascia + perinephric fat ± adrenal gland ± regional lymph nodes; does NOT include total ureterectomy; CPT 50240 (open) / 50545 (laparoscopic); used for renal cell carcinoma, NOT UTUC
Completion ureterectomy — removal of ureteral remnant/stump after prior incomplete ureterectomy or prior nephrectomy; CPT 50650 (with bladder cuff as separate procedure); coded when staging or recurrence requires it
Ureteroscopy — diagnostic and potentially therapeutic retrograde endoscopic assessment of ureter and renal pelvis; CPT 52351 (diagnostic) / 52354 (with biopsy/fulguration); used for pre-RNU staging biopsy or in surveillance
Retroperitoneal lymph node dissection (RPLND) — regional lymphadenectomy performed at time of RNU for lymph node-positive or high-grade UTUC; coded separately — CPT 38780 (retroperitoneal lymphadenectomy) appended to nephroureterectomy CPT; use modifier -51
Cystoscopy — surveillance for bladder recurrence after RNU; performed at 3 months and annually thereafter; CPT 52000 (diagnostic) or 52001 (with irrigation/evacuation)
Cisplatin-based chemotherapy — neoadjuvant or adjuvant systemic therapy for high-grade/advanced UTUC; coded during chemotherapy encounters with Z51.11 (encounter for antineoplastic chemotherapy) as principal + tumor code as additional
CODING CORNER
📋 ICD-10-CM — Nephroureterectomy Indications
⚠️ C65 (renal pelvis) and C66 (ureter) are the parent codes — they are NOT billable alone. Laterality character is required: 1 = right, 2 = left, 9 = unspecified. Do NOT use C64.x (renal cell carcinoma of kidney parenchyma) for UTUC — C64 is for renal cell carcinoma (clear cell, papillary, etc.); C65 is specifically for urothelial/transitional cell carcinoma of the renal pelvis and calyces. When both renal pelvis AND ureter are involved by tumor, code BOTH C65.x AND C66.x for the same laterality.
Genetic susceptibility to other malignant neoplasm (Lynch syndrome susceptibility — add when genetic testing positive for MMR deficiency associated with UTUC)
Personal history of malignant neoplasm of other urinary organs (post-RNU surveillance visits — replaces C65/C66 once no evidence of disease; signals prior UTUC history)
Acute kidney injury, unspecified (obstructive uropathy from ureteral UTUC causing AKI — code when documented; significant CC/MCC impact on inpatient DRG)
N18.3-
Chronic kidney disease, stage 3 (pre-existing CKD with solitary kidney or bilateral disease — affects surgical planning and coding complexity)
🔧 CPT Codes — Nephroureterectomy Procedures
⚠️ THE CRITICAL CODING RULE: The presence or absence of TOTAL ureterectomy WITH bladder cuff excision is the single code-determining factor. CPT 50234 and 50236 (open total) and CPT 50548 (laparoscopic total) require documentation of: (1) total ureter removed AND (2) bladder cuff excised. CPT 50220 (open partial) and 50546 (laparoscopic partial) apply when only a portion of the ureter is removed. When 50548 is performed laparoscopically AND the bladder cuff is removed via a separate open incision (hybrid approach), 50548 is still the correct code — 50650 is added with modifier -59 for the separately performed bladder cuff component per AAPC guidance.
Nephrectomy, including partial ureterectomy, any open approach including rib resection (partial ureterectomy only — ureter NOT fully removed; do NOT use for RNU with total ureterectomy)
Nephrectomy, including partial ureterectomy; complicated by previous surgery on same kidney (prior ipsilateral surgery adds complexity — documents prior kidney surgery in operative report)
Nephrectomy with total ureterectomy and bladder cuff; through same incision (RNU via single extended incision — total ureter + bladder cuff removed through one surgical approach)
Nephrectomy with total ureterectomy and bladder cuff; through separate incision (classic two-incision RNU — flank nephroureterectomy + separate lower abdominal/pelvic incision for bladder cuff)
Radical nephrectomy(includes removal of Gerota’s fascia, perinephric fat, regional lymph nodes, and adrenalectomy — used for renal cell carcinoma, NOT UTUC; does NOT include total ureterectomy)
Laparoscopy, surgical; radical nephrectomy (includes Gerota’s fascia, perinephric fat, regional lymph nodes, adrenalectomy — used for RCC, NOT UTUC; no total ureterectomy)
Laparoscopy, surgical; nephrectomy with total ureterectomy(gold-standard laparoscopic/robotic RNU code — total ureter AND bladder cuff excised; also used for robotic-assisted approach — no separate robotic CPT)
Ureterectomy, with bladder cuff (separate procedure)(open distal ureterectomy + bladder cuff when performed as distinct component from laparoscopic nephrectomy in hybrid approach; bill with -59 or -XS to break NCCI bundle with 50548)
Ureterectomy, total, combining laparoscopic mobilization of ureter and open excision of distal ureter (combined laparoscopic and open approach for total ureterectomy component alone)
Retroperitoneal lymphadenectomy, extensive, including pelvic, aortic, and renal nodes (performed at time of RNU for node-positive or high-grade UTUC; bill separately with modifier -51)
Distinct procedural service — required when 50650 (open bladder cuff excision) is billed alongside 50548 (laparoscopic nephroureterectomy) in a hybrid approach; breaks NCCI bundle; alternatively use -XS (separate structure) for Medicare
Separate structure — Medicare-specific X modifier equivalent to -59 for anatomically distinct components; preferred over -59 on Medicare claims for 50548 + 50650 hybrid billing
Co-surgeon — two surgeons performing distinct, documented portions of open RNU (e.g., urologist performing nephrectomy portion; pelvic/colorectal surgeon managing bladder cuff through separate incision); separate operative notes required for each surgeon
Staged procedure — planned second-stage procedure within 90-day global period (e.g., planned contralateral surveillance ureteroscopy or planned completion ureterectomy 50650 staged after initial ipsilateralRNU)
Unplanned return to OR within global period — e.g., hemorrhage, urinoma requiring drainage, bowel injury after RNU within 90-day global
⚠️ Coding Notes & Payer Guidance
Total vs. partial ureterectomy — THE code-defining distinction: The entire nephrectomy CPT code selection for UTUC hinges on one documented fact in the operative report: was the complete ureter removed along with a bladder cuff? 50548 (laparoscopic) and 50234/50236 (open) require both total ureter AND bladder cuff excised. If the operative report says “ureter ligated and divided” without confirming distal excision and bladder cuff removal, the correct codes are 50546 (laparoscopic partial) or 50220 (open partial) — significantly lower RVUs. Always review the operative report for both components before selecting the total ureterectomy code.
50548 + 50650 hybrid approach — the NCCI bundle everyone misses: When a urologist performs 50548 laparoscopically for the nephrectomy/upper ureter component but makes a separate open incision for the distal ureterectomy and bladder cuff (50650), both codes may be billed — but they will bundle under NCCI without a modifier. The correct override is modifier -59 (or -XS on Medicare) appended to 50650. Per AAPC guidance, this combination is appropriate when the operative report documents distinct proximal (laparoscopic) and distal (open) components of the same procedure. Missing the 50650 charge in this scenario is a consistent undercoding pattern in laparoscopic RNU billing.
C65.x vs. C64.x vs. C66.x — do not conflate renal malignancy codes:C64.x = renal cell carcinoma of the kidney parenchyma (clear cell, papillary, chromophobe); treated with radical nephrectomy (50240/50545). C65.x = urothelial/transitional cell carcinoma of the renal pelvis and calyces; treated with RNU (50234/50548). C66.x = urothelial carcinoma of the ureter. These three diagnoses map to entirely different CPT codes and surgical philosophies. Assigning C64 when the pathology report says “urothelial carcinoma, renal pelvis” is a high-risk audit flag.
Lynch syndrome workup — don’t miss the additional codes: UTUC in patients under age 60, bilateral disease, or personal/family history of Lynch syndrome-associated cancers (colorectal, endometrial) warrants MMR immunohistochemistry (88341/88342) and possibly MSI testing on the tumor specimen. These are separately billable pathology CPT codes from the surgical pathology (88307 for nephroureterectomy specimen — Level V), and the Lynch syndrome susceptibility code Z15.09 supports genetic counseling referral documentation.
90-day global period applies: All nephroureterectomy CPT codes carry a 90-day global period. Post-RNU cystoscopy performed within 90 days of the surgery must be billed with modifier -58 (planned staged surveillance) or -79 (unrelated procedure if truly for a distinct condition). The standard 3-month post-RNU cystoscopy for bladder surveillance is a -58 scenario as it is a planned component of the oncologic management protocol.
Crystal's MCW Coder Hub